2019

Test Your Knowledge: Plasma Exchange

September 19, 2019 // 0 Comments

We cannot wait to share the NephMadness 2020 logo at Kidney Week. Until then, we are releasing a quiz* each week from the eight regions of NephMadness 2019, starting with the Plasma Exchange region this week. Plasmapheresis, simply removal of [read more...]

Can Sevelamer Reduce Proteinuria in Patients With CKD? Do We Have An ANSWER?

September 16, 2019 // 0 Comments

In the United States, approximately 37 million people in the United States have chronic kidney disease (CKD), and in 2016, there were more than 720,000 patients with ESRD on various renal replacement therapies (hemodialysis, peritoneal dialysis, or [read more...]

Test Your Knowledge: Hypertension in CKD

September 11, 2019 // 0 Comments

A recent AJKD Core Curriculum by Ku et al reviews the pathophysiology, diagnosis, and management of hypertension in patients with chronic kidney disease (CKD). Test your knowledge on this topic with the quiz below. For a PDF version of the questions [read more...]

Highlights from the September 2019 Issue

September 4, 2019 // 0 Comments

Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers [read more...]

Hyperammonemia and Organ Transplantation

August 29, 2019 // 0 Comments

In a Perspective recently published in AJKD, Harish Seethapathy and Andrew Fenves review the increasingly recognized problem of elevated ammonia levels in the setting of organ transplantation. AJKD Social Media Editor, Timothy Yau (AJKDBlog) [read more...]

Eculizumab – Can It Be Used for MPGN and C3GN?

August 26, 2019 // 0 Comments

Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury on light microscopy that is characterized by mesangial expansion with hypercellularity, endocapillary proliferation, and double-contour formation along the glomerular [read more...]

Ethical Challenges of APOL1 Testing in Living Kidney Donors

August 21, 2019 // 0 Comments

The identification of APOL1-related kidney disease and recognition of its large contribution to excess risk of end-stage kidney disease (ESKD) in people of West African origin has been one of the biggest stories in nephrology over the past 2 decades [read more...]

Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3 CKD

August 15, 2019 // 1 Comment

There has been significant interest in SGLT2 inhibitors (SGLT2i) as novel oral anti-hyperglycemic agents that have been recently approved for the treatment of type 2 diabetes mellitus (T2DM). Studies such as CANVAS allude to their glucose-lowering [read more...]

Choosing Wisely: A Decision Aid for Dialysis Therapies to Facilitate Person-Centered Kidney Care

August 12, 2019 // 1 Comment

Shared decision-making, an approach in which clinicians and patients partner to evaluate best available evidence for treatment options, discuss risks and benefits, and make informed decisions that align with goals and values, is a central tenet of [read more...]

#PathPointer: Granulomatous Interstitial Nephritis in the Allograft Biopsy

August 7, 2019 // 0 Comments

Granulomatous inflammation in the allograft biopsy is an unusual finding that most often manifests as granulomatous interstitial nephritis (GIN). Interstitial inflammation in the allograft is mostly related to cellular rejection and macrophages can [read more...]

AJKD Blog

Official Blog of the American Journal of Kidney Diseases